# Dizal to Present Latest Clinical Data at ASH 2026

- Source: PR Newswire M&A
- Published: 2026-11-05T08:16:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/dizal-to-present-latest-clinical-data-at-ash-2026-302930459.html
- Canonical: https://groundlevelnews.com/story/dizal-to-present-latest-clinical-data-at-ash-2026-1efc7e/

Golidocitinib monotherapy showed high and durable response in adults with secondary HLH, to be featured in an oral presentation. Two oral presentations showing superior clinical benefits of birelentinib, as a single agent or in combination with a BCL2 inhibitor, in 1st line CLL/SLL...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._